Clinical experience of nusinersen in a broad spectrum of spinal muscular atrophy: A retrospective study
Background: Nusinersen has recently been approved and more widely used as first-line treatment of spinal muscular atrophy (SMA). This study aimed to evaluate the real-world experience of nusinersen use for patients with a broad spectrum of SMA. Methods: We reviewed consecutive patients with SMA trea...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Col·lecció: | Annals of Indian Academy of Neurology |
| Matèries: | |
| Accés en línia: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=6;spage=796;epage=801;aulast=Kim |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|